47 related articles for article (PubMed ID: 20704863)
1. High-throughput in vitro translation.
Diehl F; Traverso G
Discov Med; 2003 Oct; 3(18):44-5. PubMed ID: 20704863
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput nonisotopic protein truncation test.
Gite S; Lim M; Carlson R; Olejnik J; Zehnbauer B; Rothschild K
Nat Biotechnol; 2003 Feb; 21(2):194-7. PubMed ID: 12524552
[TBL] [Abstract][Full Text] [Related]
3. Detection of heterozygous nonsense mutations in genes of interest using an Escherichia coli-based stop codon assay.
Moon YJ; Kang Y; Choi JH; Lee KH
Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):137-43. PubMed ID: 16995837
[TBL] [Abstract][Full Text] [Related]
4. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
[TBL] [Abstract][Full Text] [Related]
5. Universal promoter for gene expression without cloning: expression-PCR.
Kain KC; Orlandi PA; Lanar DE
Biotechniques; 1991 Mar; 10(3):366-74. PubMed ID: 2064773
[TBL] [Abstract][Full Text] [Related]
6. A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations.
Kahmann S; Herter P; Kuhnen C; Müller KM; Muhr G; Martin D; Soddemann M; Müller O
Hum Mutat; 2002 Feb; 19(2):165-72. PubMed ID: 11793475
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques.
Andreutti-Zaugg C; Scott RJ; Iggo R
Cancer Res; 1997 Aug; 57(15):3288-93. PubMed ID: 9242462
[TBL] [Abstract][Full Text] [Related]
8. [Genetic diagnosis of familial adenomatous polyposis: detection of APC gene mutations based on an in vitro synthetized protein].
Albuquerque C; Fidalgo P; Chagas C; Suspiro A; Cravo M; Ramalho E; Leitão CN; Mira FC
Acta Med Port; 1998 Jan; 11(1):25-32. PubMed ID: 9580364
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic ribosome display with in situ DNA recovery.
He M; Taussig MJ
Nat Methods; 2007 Mar; 4(3):281-8. PubMed ID: 17327849
[TBL] [Abstract][Full Text] [Related]
10. In vitro generation of anti-hepatitis B monoclonal antibodies from a single plasma cell using single-cell RT-PCR and cell-free protein synthesis.
Sabrina Y; Ali M; Nakano H
J Biosci Bioeng; 2010 Jan; 109(1):75-82. PubMed ID: 20129087
[TBL] [Abstract][Full Text] [Related]
11. A completely in vitro ultrahigh-throughput droplet-based microfluidic screening system for protein engineering and directed evolution.
Fallah-Araghi A; Baret JC; Ryckelynck M; Griffiths AD
Lab Chip; 2012 Mar; 12(5):882-91. PubMed ID: 22277990
[TBL] [Abstract][Full Text] [Related]
12. An alternative method to amplify RNA without loss of signal conservation for expression analysis with a proteinase DNA microarray in the ArrayTube format.
Schüler S; Wenz I; Wiederanders B; Slickers P; Ehricht R
BMC Genomics; 2006 Jun; 7():144. PubMed ID: 16768788
[TBL] [Abstract][Full Text] [Related]
13. [Development and establishment of a yeast-based stop codon assay for detection of NF2 gene premature-terminating mutations].
Kobayashi H
Hokkaido Igaku Zasshi; 1999 Sep; 74(5):377-86. PubMed ID: 10495852
[TBL] [Abstract][Full Text] [Related]
14. Ectopic transcript analysis indicates that allelic exclusion is an important cause of type I protein C deficiency in patients with nonsense and frameshift mutations in the PROC gene.
Soria JM; Berg LP; Fontcuberta J; Kakkar VV; Estivill X; Cooper DN; Sala N
Thromb Haemost; 1996 Jun; 75(6):870-6. PubMed ID: 8822578
[TBL] [Abstract][Full Text] [Related]
15. A novel strategy for generation of monoclonal antibodies from single B cells using rt-PCR technique and in vitro expression.
Jiang X; Suzuki H; Hanai Y; Wada F; Hitomi K; Yamane T; Nakano H
Biotechnol Prog; 2006; 22(4):979-88. PubMed ID: 16889373
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of Stickler syndrome: a COL2A1 stop codon mutation screening strategy that is not compromised by mutant mRNA instability.
Freddi S; Savarirayan R; Bateman JF
Am J Med Genet; 2000 Feb; 90(5):398-406. PubMed ID: 10706362
[TBL] [Abstract][Full Text] [Related]
17. Identification of the template-binding cleft of T7 RNA polymerase as the site for promoter binding by photochemical cross-linking with psoralen.
Sastry SS
Biochemistry; 1996 Oct; 35(42):13519-30. PubMed ID: 8885831
[TBL] [Abstract][Full Text] [Related]
18. Screening for unknown mutations by a bioluminescent protein truncation test with homogeneous detection.
Petrakis EC; Trantakis IA; Kalogianni DP; Christopoulos TK
J Am Chem Soc; 2010 Apr; 132(14):5091-5. PubMed ID: 20232860
[TBL] [Abstract][Full Text] [Related]
19. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
Hatfield GW; Roth DA
Biotechnol Annu Rev; 2007; 13():27-42. PubMed ID: 17875472
[TBL] [Abstract][Full Text] [Related]
20. Mouse testin: complementary DNA cloning, genomic organization, and characterization of its proximal promoter region.
Cheng CK; Cheung CH; Lee WM
Biol Reprod; 2003 Apr; 68(4):1376-86. PubMed ID: 12606342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
